Mounjaro 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FU5MQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,499
Award facts
- Contract value 100% obligated
- $12,499.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injections with a ceiling value of $12.5K. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1B global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. The company holds an extensive portfolio of federal contracts with the Defense Logistics Agency covering diverse pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The delivery of Mounjaro, a diabetes medication, supports the company's established role in providing endocrinology treatments and other specialized pharmaceutical commodities to Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FU5MQ?
SPE2DB25FU5MQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FU5MQ worth?
The government has obligated $12,499 on SPE2DB25FU5MQ.
Is contract SPE2DB25FU5MQ an order under another contract?
Yes. SPE2DB25FU5MQ is a delivery order under SPE2DB22D2108, an indefinite delivery contract.
Was contract SPE2DB25FU5MQ competed?
The extent of competition for SPE2DB25FU5MQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award